Nearly half (48.6%) of the individuals with a score higher than 58 on the model—which they identified as a threshold for ...
Humacyte, Inc. recently announced the presentation of results from the V007 phase 3 clinical trial of the company’s acel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback